Walter Maksymowych, McGill University

Research

Latest funding

Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries
CIHR · 2019 · Co-investigator
$2,550,000
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
CIHR · 2017 · Principal investigator
$1,769,650
Identification of Novel Copy Number Variants using a Custom Genome Wide Microarray Chip for Diagnosis of Familial Spondyloarthritis
CIHR · 2012 · Co-investigator
$146,389

Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries

Co-investigatorCIHR2019DSEN team grants: MAGIC and CAN-AIM

Principal investigators: Bernatsky, Sasha R; Abrahamowicz, Michal M; Afif, Waqqas; Awadalla, Philip; Bérard, Anick; Buckeridge, David L; Hazlewood, Glen S; Hohl, Corinne M; Kowalec, Kaarina A; Moride, Yola; Moura, Cristiano S; Pilote, Louise; Tremlett, Helen L

Keywords: Comparative Effectiveness And Safety; Confounding Bias; Exposure Measurement Errors; Pharmacoepidemiology; Prospective Studies; Statistical Modelling

$2,550,000

Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs

Principal investigatorCIHR2017Rapid Funding for DSEN Targeted Research

Principal investigators: Bernatsky, Sasha R; Boire, Gilles; Bykerk, Vivian P; Lakatos, Peter; Maksymowych, Walter P; Moura, Cristiano S; Targownik, Laura E

Keywords: Des

$1,769,650

Identification of Novel Copy Number Variants using a Custom Genome Wide Microarray Chip for Diagnosis of Familial Spondyloarthritis

Co-investigatorCIHR2012Operating Grant - PA: Regional Partnership Program - Newfoundland and Labrador

Principal investigators: Rahman, Proton

Keywords: Ankylosing Spondylitis; Copy Number Variations; Missing Heritability; Psoriatic Arthritis; Structural Variations

$146,389

Post Market Drug Safety and Effectiveness: Ankylosing Spondylitis

Co-investigatorCIHR2012Catalyst Grant: Post Market DSE - DMARD in patients with ankylosing spondylitis

Principal investigators: Bernatsky, Sasha R; Rahme, Elham

Keywords: Ankylosing Spondylitis; Arthritis; Disease-Modifying Anti-Rheumatic Drugs; Dmards; Drug Effectiveness; Drug Safety

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Subject: Prospective PhD student: Des Dear Professor Maksymowych, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on des connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]